![](/img/cover-not-exists.png)
6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis
Evangelia Xingi, Despina Smirlis, Vassilios Myrianthopoulos, Prokopios Magiatis, Karen M. Grant, Laurent Meijer, Emmanuel Mikros, Alexios-Leandros Skaltsounis, Ketty SoteriadouVolume:
39
Year:
2009
Language:
english
Pages:
15
DOI:
10.1016/j.ijpara.2009.04.005
File:
PDF, 932 KB
english, 2009